Search

Acute kidney injury (AKI) occurred in 12.8% of patients undergoing surgery and is associated with increased mortality. Chronic kidney disease (CKD) is a well-known risk for death and cardiovascular disease (CVD). Effects of AKI and CKD on patients undergoing coronary angiography (CAG) remain incompletely defined. The aim of our study was to investigate the relationship between acute and CKD and mortality in patients undergoing CAG. The cohort study included 49,194 patients in the multicenter cohort from January 2007 to December 2018. Cox regression analyses and Fine-Gray proportional subdistribution risk regression analysis are used to examine the association between kidney disease and all-cause and cardiovascular mortality. In the present study, 13,989 (28.4%) patients had kidney disease. During follow-up, 6144 patients died, of which 4508 (73.4%) were due to CVD. AKI without CKD (HR: 1.54, 95% CI: 1.36–1.74), CKD without AKI (HR: 2.02, 95% CI: 1.88–2.17), AKI with CKD (HR: 3.26, 95% CI: 2.90–3.66), and end-stage kidney disease (ESKD; HR: 5.63, 95% CI: 4.40–7.20) were significantly associated with all-cause mortality. Adjusted HR (95% CIs) for cardiovascular mortality was significantly elevated among patients with AKI without CKD (1.78 [1.54–2.06]), CKD without AKI (2.28 [2.09–2.49]), AKI with CKD (3.99 [3.47–4.59]), and ESKD (6.46 [4.93–8.46]). In conclusion, this study shows that acute or CKD is present in up to one-third of patients undergoing CAG and is associated with a substantially increased mortality. These findings highlight the importance of perioperative management of kidney function, especially in patients with CKD. What is already known on this subject? Acute kidney injury (AKI) occurred in 12.8% of patients undergoing surgery and is linked to a 22.2% increase in mortality. Chronic kidney disease (CKD) is a well-known risk for death and cardiovascular events. Effects of AKI and CKD on patients undergoing coronary angiography (CAG) remain incompletely defined. What do the results of this study add? This study shows that kidney disease is present in up to one-third of patients undergoing CAG and is associated with a substantially increased mortality. AKI and CKD are independent predicators for mortality in patients undergoing CAG. What are the implications of these findings for clinical practice and/or further research? These findings highlight the importance of perioperative management of kidney function, especially in patients with CKD. [ABSTRACT FROM AUTHOR]

Copyright of CyTA: Journal of Food is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Wearable ionization air cleaners are compact in size and marketed for personal respiratory protection by removing air pollutants from users' breathing zone. In this study, ozone emission and particle removal rates of four wearable ionization air cleaners (namely, AC1 through AC4) were evaluated inside a 0.46 m3stainless steel chamber. Continuous measurements were conducted for ozone concentration, PM2.5concentration, and particle size distribution in the size range of 18.1–289 nm. Two of the four wearable air cleaners (i.e., AC1 and AC2) had detectable ozone emissions. The 10-h average ozone emission rates were quite different (i.e., 0.67 mg·h−1for AC1 and 3.40 × 10−2mg·h−1for AC2); however, the ozone emissions were negligible for AC3 and AC4. The number removal rates for particles within the measured size range were highly variable (i.e., 2.20 h−1, 0.52 h−1, 8.10 h−1, and 27.9 h−1for AC1 through AC4, respectively). The corresponding mass removal rates of PM2.5were 1.85 h−1, 0.48 h−1,1.52 h−1, and 5.37 h−1, respectively. Regulatory guidelines are needed to assure these devices can effectively remove particles without ozone emissions to protect public health. Copyright © 2016 American Association for Aerosol Research [ABSTRACT FROM AUTHOR]